IR-Med, Inc. Files 8-K Reporting Other Events
Ticker: IRME · Form: 8-K · Filed: Apr 5, 2024 · CIK: 1839133
| Field | Detail |
|---|---|
| Company | Ir-Med, Inc. (IRME) |
| Form Type | 8-K |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing
TL;DR
IR-Med, Inc. filed an 8-K on 4/5/24. Formerly International Display Advertising.
AI Summary
IR-Med, Inc. filed an 8-K on April 5, 2024, reporting other events and financial statements. The company, formerly known as International Display Advertising, Inc. until January 5, 2021, is incorporated in Nevada and has its principal executive offices in Rosh Pina, Israel.
Why It Matters
This filing indicates IR-Med, Inc. is providing updates on its corporate activities and financial status, which is important for investors to monitor company developments.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting other events and financial statements, with no immediate indication of significant financial distress or major corporate changes.
Key Players & Entities
- IR-Med, Inc. (company) — Filer
- International Display Advertising, Inc. (company) — Former company name
- April 5, 2024 (date) — Date of report
- January 5, 2021 (date) — Date of name change
- Nevada (jurisdiction) — State of incorporation
- Rosh Pina, Israel (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for IR-Med, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits'.
When was IR-Med, Inc. formerly known by another name?
IR-Med, Inc. was formerly known as International Display Advertising, Inc. until January 5, 2021.
In which state is IR-Med, Inc. incorporated?
IR-Med, Inc. is incorporated in Nevada.
What is the principal executive office address for IR-Med, Inc.?
The principal executive offices of IR-Med, Inc. are located at ZHR Industrial Zone Rosh Pina Israel.
What is the filing date of this Current Report?
The filing date of this Current Report is April 5, 2024.
Filing Stats: 416 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-04-05 09:15:03
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 18KB
- image_001.jpg (GRAPHIC) — 4KB
- ex99-1_002.jpg (GRAPHIC) — 6KB
- 0001493152-24-013260.txt ( ) — 237KB
- irme-20240405.xsd (EX-101.SCH) — 3KB
- irme-20240405_lab.xml (EX-101.LAB) — 33KB
- irme-20240405_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IR-Med, Inc. By: /s/ Sharon Lefkoviz Name: Sharon Lefkoviz Title: Chief Financial Officer Date: April 5, 2024